Anil Modak

1.4k total citations
50 papers, 1.0k citations indexed

About

Anil Modak is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Anil Modak has authored 50 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 12 papers in Pharmacology and 9 papers in Oncology. Recurrent topics in Anil Modak's work include Pharmacogenetics and Drug Metabolism (12 papers), Metabolomics and Mass Spectrometry Studies (11 papers) and Analytical Chemistry and Chromatography (8 papers). Anil Modak is often cited by papers focused on Pharmacogenetics and Drug Metabolism (12 papers), Metabolomics and Mass Spectrometry Studies (11 papers) and Analytical Chemistry and Chromatography (8 papers). Anil Modak collaborates with scholars based in United States, Netherlands and United Kingdom. Anil Modak's co-authors include Lori K. Mattison, Robert B. Diasio, Jeanne Fourie, James K. Bashkin, Muhammad Wasif Saif, Renée A. Desmond, Hany Ezzeldin, Martin R. Johnson, Mark Carpenter and Janice K. Gard and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Anil Modak

50 papers receiving 924 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anil Modak United States 17 512 252 155 150 122 50 1.0k
Henri Bénech France 24 393 0.8× 230 0.9× 122 0.8× 136 0.9× 121 1.0× 66 1.7k
Alain Deroussent France 21 529 1.0× 402 1.6× 149 1.0× 48 0.3× 62 0.5× 47 1.5k
Tommy Eriksson Sweden 12 381 0.7× 196 0.8× 88 0.6× 61 0.4× 138 1.1× 15 815
Enaksha Wickremsinhe United States 19 310 0.6× 226 0.9× 68 0.4× 124 0.8× 98 0.8× 43 858
Marina H. de Jager Netherlands 17 277 0.5× 437 1.7× 303 2.0× 171 1.1× 37 0.3× 26 1.2k
Eiji Matsushima Japan 14 201 0.4× 277 1.1× 82 0.5× 41 0.3× 83 0.7× 44 729
Yuguang Wang China 13 233 0.5× 60 0.2× 108 0.7× 69 0.5× 81 0.7× 49 975
Ayaka Suenaga Japan 18 544 1.1× 215 0.9× 51 0.3× 42 0.3× 77 0.6× 42 925
Chandan Singh India 17 331 0.6× 130 0.5× 25 0.2× 156 1.0× 120 1.0× 33 883
Mark G. Qian United States 18 371 0.7× 203 0.8× 81 0.5× 201 1.3× 306 2.5× 47 909

Countries citing papers authored by Anil Modak

Since Specialization
Citations

This map shows the geographic impact of Anil Modak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anil Modak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anil Modak more than expected).

Fields of papers citing papers by Anil Modak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anil Modak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anil Modak. The network helps show where Anil Modak may publish in the future.

Co-authorship network of co-authors of Anil Modak

This figure shows the co-authorship network connecting the top 25 collaborators of Anil Modak. A scholar is included among the top collaborators of Anil Modak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anil Modak. Anil Modak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Modak, Anil. (2023). Why have only a handful of breath tests made the transition from R&D to clinical practice?. Journal of Breath Research. 18(1). 12001–12001. 3 indexed citations
2.
Modak, Anil. (2017). Point-of-care companion diagnostic tests for personalizing psychiatric medications: fulfilling an unmet clinical need. Journal of Breath Research. 12(1). 17101–17101. 4 indexed citations
3.
4.
5.
Safgren, Stephanie L., Vera J. Suman, Matthew Kosel, et al.. (2015). Evaluation of CYP2D6 enzyme activity using a 13C-dextromethorphan breath test in women receiving adjuvant tamoxifen. Pharmacogenetics and Genomics. 25(4). 157–163. 10 indexed citations
6.
Opdam, Frans L., Anil Modak, Simon P. Mooijaart, et al.. (2015). CYP2D6 Metabolism in Frail Elderly Compared to Non-Frail Elderly: A Pilot Feasibility Study. Drugs & Aging. 32(12). 1019–1027. 10 indexed citations
7.
Klieber, Martin, Herbert Oberacher, Beate Beer, et al.. (2015). CYP2C19 Phenoconversion by Routinely Prescribed Proton Pump Inhibitors Omeprazole and Esomeprazole: Clinical Implications for Personalized Medicine. Journal of Pharmacology and Experimental Therapeutics. 354(3). 426–430. 29 indexed citations
8.
Modak, Anil. (2013). Regulatory issues on breath tests and updates of recent advances on [13C]-breath tests. Journal of Breath Research. 7(3). 37103–37103. 16 indexed citations
9.
Opdam, Frans L., Anil Modak, Hans Gelderblom, & Henk‐Jan Guchelaar. (2013). Breath Tests to Phenotype Drug Disposition in Oncology. Clinical Pharmacokinetics. 52(11). 919–926. 4 indexed citations
10.
Thacker, David, Anil Modak, David A. Flockhart, & Zeruesenay Desta. (2012). Is (+)-[ 13 C]-pantoprazole better than (±)-[ 13 C]-pantoprazole for the breath test to evaluate CYP2C19 enzyme activity?. Journal of Breath Research. 7(1). 16001–16001. 9 indexed citations
11.
Opdam, Frans L., Vincent O. Dezentjé, Jan den Hartigh, et al.. (2012). The use of the 13C-dextromethorphan breath test for phenotyping CYP2D6 in breast cancer patients using tamoxifen: association with CYP2D6 genotype and serum endoxifen levels. Cancer Chemotherapy and Pharmacology. 71(3). 593–601. 23 indexed citations
12.
Thacker, David, Anil Modak, Phuong D. Nguyen, David A. Flockhart, & Zeruesenay Desta. (2011). Stereoselective pharmacokinetics of stable isotope (+/−)‐[13C]‐pantoprazole: Implications for a rapid screening phenotype test of CYP2C19 activity. Chirality. 23(10). 904–909. 21 indexed citations
13.
Modak, Anil. (2009). 13C breath tests in personalized medicine: fiction or reality?. Expert Review of Molecular Diagnostics. 9(8). 805–815. 4 indexed citations
14.
Modak, Anil. (2009). Single time point diagnostic breath tests: a review. Journal of Breath Research. 4(1). 17002–17002. 13 indexed citations
15.
Ezzeldin, Hany, Edward P. Acosta, Lori K. Mattison, et al.. (2009). 13 C-5-FU breath test current status and future directions: a comprehensive review. Journal of Breath Research. 3(4). 47002–47002. 9 indexed citations
16.
Desta, Zeruesenay, Anil Modak, Phuong D. Nguyen, et al.. (2009). Rapid Identification of the Hepatic Cytochrome P450 2C19 Activity Using a Novel and Noninvasive [13C]Pantoprazole Breath Test. Journal of Pharmacology and Experimental Therapeutics. 329(1). 297–305. 32 indexed citations
17.
Modak, Anil. (2009). Breath tests with 13 C substrates. Journal of Breath Research. 3(4). 40201–40201. 13 indexed citations
18.
Leeder, J. Steven, Robin E. Pearce, Andrea Gaedigk, Anil Modak, & David I. Rosen. (2008). Evaluation of a [13C]‐Dextromethorphan Breath Test to Assess CYP2D6 Phenotype. The Journal of Clinical Pharmacology. 48(9). 1041–1051. 26 indexed citations
19.
Modak, Anil. (2007). Stable isotope breath tests in clinical medicine: a review. Journal of Breath Research. 1(1). 14003–14003. 52 indexed citations
20.
Freeman, Richard B., et al.. (2007). L-[1- 13 C] phenylalanine breath test for monitoring hepatic function after living donor liver transplant surgery. Journal of Breath Research. 1(2). 26002–26002. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Henri Bénech Breakdown of academic impact, for papers by Alain Deroussent Breakdown of academic impact, for papers by Tommy Eriksson Breakdown of academic impact, for papers by Enaksha Wickremsinhe Breakdown of academic impact, for papers by Marina H. de Jager Breakdown of academic impact, for papers by Eiji Matsushima Breakdown of academic impact, for papers by Yuguang Wang Breakdown of academic impact, for papers by Ayaka Suenaga Breakdown of academic impact, for papers by Chandan Singh Breakdown of academic impact, for papers by Mark G. Qian
Rankless by CCL
2026